ISIN | LU2295702851 |
---|---|
Valor Number | 59784141 |
Bloomberg Global ID | CSLEECU LX |
Fund Name | UBS (Lux) Fund Solutions II - UBS MSCI Europe Index Fund USD I-W-SSP acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | Equity Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Subfund tracks the MSCI Europe Index as its benchmark index. The Investment Objective of the Subfund is to provide the Shareholders with a return in line with the performance of the MSCI Europe Index (the “Underlying Index”) (see description under the section “Description of the Underlying Index”). |
Peculiarities |
Current Price * | 1,339.68 USD | 03.09.2025 |
---|---|---|
Previous Price * | 1,330.51 USD | 02.09.2025 |
52 Week High * | 1,379.21 USD | 22.08.2025 |
52 Week Low * | 1,071.09 USD | 13.01.2025 |
NAV * | 1,339.68 USD | 03.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 145,418,203 | |
Unit/Share Assets *** | 26,063,899 | |
Trading Information SIX |
YTD Performance | +23.66% |
31.12.2024 - 03.09.2025
31.12.2024 03.09.2025 |
---|---|---|
YTD Performance (in CHF) | +9.49% |
31.12.2024 - 03.09.2025
31.12.2024 03.09.2025 |
1 month | +2.41% |
04.08.2025 - 03.09.2025
04.08.2025 03.09.2025 |
3 months | +2.27% |
03.06.2025 - 03.09.2025
03.06.2025 03.09.2025 |
6 months | +9.68% |
03.03.2025 - 03.09.2025
03.03.2025 03.09.2025 |
1 year | +13.21% |
03.09.2024 - 03.09.2025
03.09.2024 03.09.2025 |
2 years | +34.08% |
04.09.2023 - 03.09.2025
04.09.2023 03.09.2025 |
3 years | +65.12% |
05.09.2022 - 03.09.2025
05.09.2022 03.09.2025 |
5 years | +33.97% |
04.10.2021 - 03.09.2025
04.10.2021 03.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.51% | |
---|---|---|
Nestle SA | 2.34% | |
ASML Holding NV | 2.18% | |
Roche Holding AG | 1.93% | |
Novartis AG Registered Shares | 1.88% | |
AstraZeneca PLC | 1.86% | |
Novo Nordisk AS Class B | 1.80% | |
HSBC Holdings PLC | 1.68% | |
Shell PLC | 1.68% | |
Siemens AG | 1.45% | |
Last data update | 30.04.2025 |
TER | 0.85% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.50% |
Ongoing Charges *** | 0.84% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |